NEW YORK (GenomeWeb) — Roche said today that its Cobas MPX and Cobas WNV assays can now be used for testing of human organ and tissue from cadaveric donors, thus expanding the range of approved uses for the Cobas 6600/8800 systems in markets recognizing CE marking.

The new claims allow for pre-transplantation testing of organ and tissue donations to protect transplant recipients from the donation-related transmission of HIV, hepatitis B virus, hepatitis C virus, and West Nile virus.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers find that historical factors influence which genes are the most highly studied, the Atlantic reports.

The US National Science Foundation's new sexual harassment policy is to go into effect next month, according to Nature News.

Researchers report using genotyping to tie together illegal ivory shipments and trace them back to a handful of cartels, the New York Times reports.

In Nature this week: genomic ancestry analysis of Sardinians, current noncoding mutations in colorectal cancer, and more.

Oct
02
Sponsored by
Roche

In the last few years several molecular testing methodologies — such as immunohistochemistry, PCR, and sequencing — have been approved by the US Food and Drug Administration to aid in the management of patients with lung cancer.  

Oct
10
Sponsored by
Philips Genomics

This webinar will provide a first-hand look at how the Dana-Farber Cancer Center is adapting its oncology care strategy in light of the rapidly evolving molecular landscape.